Menu
Live News EQUITY H impact

AbbVie Nears $11B Apogee Deal

AbbVie is closing in on a nearly $11 billion deal for biotech company Apogee Therapeutics

ABBV

AbbVie Closes In On Nearly $11 Bln Deal For Biotech Apogee Therapeutics – FT